Hakutulokset - Viviane Gresset-Bourgeois

A trivalent, inactivated influenza vaccine (Vaxigrip®): summary of almost 50 years of experience and more than 1.8 billion doses distributed in over 120 countries Tekijä Margaret Haugh, Viviane Gresset-Bourgeois, Bérengère Macabeo, Anne Woods, Sandrine I. Samson

Connect to this object online.

Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in pregnant women: a randomized, observer-blind trial Tekijä Timo Vesikari, Miia Virta, Seppo Heinonen, Cécile Eymin, Nathalie Lavis, Anne Laure Chabanon, Viviane Gresset-Bourgeois

Connect to this object online.

Quadrivalent inactivated influenza vaccine (VaxigripTetra™) Tekijä Viviane Gresset-Bourgeois, Phillip S. Leventhal, Stéphanie Pepin, Rosalind Hollingsworth, Marie-Pierre, Iris De Bruijn, Sandrine I. Samson

Connect to this object online.

Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India Tekijä Sharad Agarkhedkar, Jugesh Chhatwal, Rajeev Zachariah Kompithra, Sanjay K. Lalwani, Arun Narayan, Vinay Muninarayanaswam, Nithya Gogtay, Kristin Dotter, Viviane Gresset-Bourgeois

Connect to this object online.